Why Is CHARLES RIV LABORATO (CRL) Stock Moving Today?

Charles River Laboratories International (CRL) shares rose 7.06% to $332.72 in morning trading on Monday following the announcement of a new digital laboratory execution platform in partnership with Autolomous. The stock opened with a 1.0% gap up and surged to a session high of $332.80 shortly after the market opened. The move reflects investor optimism around the company’s strategic collaboration to enhance digital capabilities in laboratory execution.

What Happened

CRL and Autolomous launched Apollo Orchestrate, a digital solution integrated into Charles River’s operations to streamline laboratory execution. The product leverages Autolomate technology to digitize processes, aiming to improve efficiency and reduce manual workflows. The partnership was announced in multiple reports over the past 36 hours, with details highlighting the integration of digital tools to modernize lab execution systems. This collaboration is positioned as a transformative step in the company’s digital strategy.

What The Data Shows

The stock opened at $313.79 and climbed to a high of $332.80, a level that surpasses its 52-week high of $312.26. Volume in the session reached 0.2 million shares, matching the 3-month average. Over the past eight sessions, the stock has risen 3.2% from $294.44 to $303.96. The stock also hit a fresh 52-week high on October 6. Recent insider transactions show mixed activity, with $3,000 in buys and $25.7 million in sells reported in the last 90 days.

What To Watch

The stock is set to continue its momentum in the near term. Analysts from UBS, Jefferies, and Deutsche Bank have maintained or raised price targets recently, with UBS setting a $357 target. Investors may monitor the stock’s performance ahead of any potential earnings release or further strategic updates.

Why is CRL stock moving today?

CHARLES RIV LABORATO (CRL) is drawing unusual attention today. Our newswire has captured 2 stories on CRL across 2 sources in the last 36 hours, with AI sentiment reading bullish (avg 58/100). The most recent driver: "Charles River announces investments, enhancements across Microbial Solutions" (The Fly).

Is CRL a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of CRL coverage reads 58/100 over 2 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.